Literature DB >> 22535301

Pellagra encephalopathy as a differential diagnosis for Creutzfeldt-Jakob disease.

Istvan Kapas1, Katalin Majtenyi, Klara Törö, Eva Keller, Till Voigtländer, Gabor G Kovacs.   

Abstract

In the present study we evaluated cases referred as suspected Creutzfeldt-Jakob disease (CJD). Five out of 59 without prion disease showed neuropathological features of pellagra encephalopathy with widespread chromatolytic neurons (age range 40-48 years at death; one woman). These patients presented with a progressive neuropsychiatric disorder lasting for 2 to 24 months. Common symptoms included gait disorder, para- or tetraspasticity, extrapyramidal symptoms, incontinence, and myoclonus. Protein 14-3-3 in the cerebrospinal fluid was examined in a single patient and was positive, allowing the clinical classification as probable sporadic CJD. Pellagra encephalopathy may be considered as a differential diagnosis of CJD including detection of protein 14-3-3.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22535301     DOI: 10.1007/s11011-012-9308-8

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  15 in total

1.  Pellagra: an old enemy of timeless importance.

Authors:  Thomas M Brown
Journal:  Psychosomatics       Date:  2010 Mar-Apr       Impact factor: 2.386

Review 2.  Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases.

Authors:  G G Kovacs; H Budka
Journal:  Clin Neuropathol       Date:  2010 Sep-Oct       Impact factor: 1.368

3.  Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease.

Authors:  Numthip Chitravas; Richard S Jung; Diane M Kofskey; Janis E Blevins; Pierluigi Gambetti; R John Leigh; Mark L Cohen
Journal:  Ann Neurol       Date:  2011-06-14       Impact factor: 10.422

4.  Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance.

Authors:  U Heinemann; A Krasnianski; B Meissner; D Varges; K Kallenberg; W J Schulz-Schaeffer; B J Steinhoff; E M Grasbon-Frodl; H A Kretzschmar; I Zerr
Journal:  Brain       Date:  2007-05       Impact factor: 13.501

5.  Rapidly progressive neurodegenerative dementias.

Authors:  Keith A Josephs; J Eric Ahlskog; Joseph E Parisi; Bradley F Boeve; Brian A Crum; Caterina Giannini; Ronald C Petersen
Journal:  Arch Neurol       Date:  2009-02

6.  Molecular diagnosis of human prion disease.

Authors:  Isabelle Quadrio; Armand Perret-Liaudet; Gabor G Kovacs
Journal:  Expert Opin Med Diagn       Date:  2011-05-27

7.  The clinical spectrum of alcoholic pellagra encephalopathy. A retrospective analysis of 22 cases studied pathologically.

Authors:  M Serdaru; C Hausser-Hauw; D Laplane; A Buge; P Castaigne; M Goulon; F Lhermitte; J J Hauw
Journal:  Brain       Date:  1988-08       Impact factor: 13.501

8.  Chromatolysis in alcoholic encephalopathies. Pellagra-like changes in 22 cases.

Authors:  J J Hauw; C De Baecque; C Hausser-Hauw; M Serdaru
Journal:  Brain       Date:  1988-08       Impact factor: 13.501

9.  Pellagra encephalopathy among tuberculous patients: its relation to isoniazid therapy.

Authors:  N Ishii; Y Nishihara
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-07       Impact factor: 10.154

10.  Pellagra among chronic alcoholics: clinical and pathological study of 20 necropsy cases.

Authors:  N Ishii; Y Nishihara
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-03       Impact factor: 10.154

View more
  2 in total

1.  Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity?

Authors:  Gabor G Kovacs; Alexander Peden; Serge Weis; Romana Höftberger; Anna S Berghoff; Helen Yull; Thomas Ströbel; Stefan Koppi; Regina Katzenschlager; Dieter Langenscheidt; Hamid Assar; Elisabeth Zaruba; Albrecht Gröner; Till Voigtländer; Gina Puska; Eva Hametner; Astrid Grams; Armin Muigg; Michael Knoflach; Lajos László; James W Ironside; Mark W Head; Herbert Budka
Journal:  Acta Neuropathol Commun       Date:  2013-11-11       Impact factor: 7.801

Review 2.  Meat Intake and the Dose of Vitamin B3 - Nicotinamide: Cause of the Causes of Disease Transitions, Health Divides, and Health Futures?

Authors:  Lisa J Hill; Adrian C Williams
Journal:  Int J Tryptophan Res       Date:  2017-05-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.